Glenmark Pharma launches lacosamide oral solution, 10 mg/mL in US markets: Our Bureau, Mumbai Monday, December 16, 2024, 12:45 Hrs [IST] Glenmark Pharmaceuticals Inc., USA (Glenma ...
Sanofi’s tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis receives US FDA breakthrough therapy designation: Paris Monday, December 16, 2024, 12:00 Hr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback